Your browser doesn't support javascript.
loading
Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods.
Amedro, Pascal; Werner, Oscar; Abassi, Hamouda; Boisson, Aymeric; Souilla, Luc; Guillaumont, Sophie; Calderon, Johanna; Requirand, Anne; Vincenti, Marie; Pommier, Victor; Matecki, Stefan; De La Villeon, Gregoire; Lavastre, Kathleen; Lacampagne, Alain; Picot, Marie-Christine; Beyler, Constance; Delclaux, Christophe; Dulac, Yves; Guitarte, Aitor; Charron, Philippe; Denjoy-Urbain, Isabelle; Probst, Vincent; Baruteau, Alban-Elouen; Chevalier, Philippe; Di Filippo, Sylvie; Thambo, Jean-Benoit; Bonnet, Damien; Pasquie, Jean-Luc.
Afiliação
  • Amedro P; Department of Paediatric and Adult Congenital Cardiology, M3C National Reference Centre, Haut-Lévêque Cardiology Hospital, Bordeaux University Hospital, Avenue de Magellan, 33604, Pessac Cedex, France. pascal.amedro@gmail.com.
  • Werner O; INSERM, Bordeaux Cardio-Thoracic Research Centre, U1045, University of Bordeaux, Pessac, France. pascal.amedro@gmail.com.
  • Abassi H; IHU Liryc, Electrophysiology and Heart Modelling Institute, Fondation Bordeaux Université, Pessac, France. pascal.amedro@gmail.com.
  • Boisson A; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Souilla L; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Guillaumont S; PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.
  • Calderon J; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Requirand A; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Vincenti M; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Pommier V; Paediatric Cardiology and Rehabilitation Unit, Institut-Saint-Pierre, Palavas-Les-Flots, France.
  • Matecki S; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • De La Villeon G; PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.
  • Lavastre K; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Lacampagne A; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Picot MC; PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.
  • Beyler C; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Delclaux C; Paediatric Cardiology and Rehabilitation Unit, Institut-Saint-Pierre, Palavas-Les-Flots, France.
  • Dulac Y; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Guitarte A; PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.
  • Charron P; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Denjoy-Urbain I; Paediatric Cardiology and Rehabilitation Unit, Institut-Saint-Pierre, Palavas-Les-Flots, France.
  • Probst V; Paediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, Montpellier University Hospital, Montpellier, France.
  • Baruteau AE; PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France.
  • Chevalier P; Epidemiology and Clinical Research Department, Montpellier University Hospital, Montpellier, France.
  • Di Filippo S; Paediatric Cardiology and Physiology Department, Robert Debré University Hospital, University of Paris, AP-HP, Paris, France.
  • Thambo JB; Paediatric Cardiology and Physiology Department, Robert Debré University Hospital, University of Paris, AP-HP, Paris, France.
  • Bonnet D; Paediatric Cardiology Department, M3C Regional Reference Centre, Toulouse University Hospital, Toulouse, France.
  • Pasquie JL; Paediatric Cardiology Department, M3C Regional Reference Centre, Toulouse University Hospital, Toulouse, France.
Health Qual Life Outcomes ; 19(1): 187, 2021 Jul 28.
Article em En | MEDLINE | ID: mdl-34321045
BACKGROUND: Advances in paediatric cardiology have improved the prognosis of children with inherited cardiac disorders. However, health-related quality of life (QoL) and physical activity have been scarcely analysed in children with inherited cardiac arrhythmia or inherited cardiomyopathy. Moreover, current guidelines on the eligibility of young athletes with inherited cardiac disorders for sports participation mainly rely on expert opinions and remain controversial. METHODS: The QUALIMYORYTHM trial is a multicentre observational controlled study. The main objective is to compare the QoL of children aged 6 to 17 years old with inherited cardiac arrhythmia (long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, or arrhythmogenic right ventricular dysplasia), or inherited cardiomyopathy (hypertrophic, dilated, or restrictive cardiomyopathy), to that of age and gender-matched healthy subjects. The secondary objective is to assess their QoL according to the disease's clinical and genetic characteristics, the level of physical activity and motivation for sports, the exercise capacity, and the socio-demographic data. Participants will wear a fitness tracker (ActiGraph GT3X accelerometer) for 2 weeks. A total of 214 children are required to observe a significant difference of 7 ± 15 points in the PedsQL, with a power of 90% and an alpha risk of 5%. DISCUSSION: After focusing on the survival in children with inherited cardiac disorders, current research is expanding to patient-reported outcomes and secondary prevention. The QUALIMYORYTHM trial intends to improve the level of evidence for future guidelines on sports eligibility in this population. Trial registration ClinicalTrials.gov Identifier: NCT04712136, registered on January 15th, 2021 ( https://clinicaltrials.gov/ct2/show/NCT04712136 ).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arritmias Cardíacas / Qualidade de Vida / Exercício Físico / Cardiomiopatias Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspecto: Patient_preference Limite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Health Qual Life Outcomes Assunto da revista: SAUDE PUBLICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arritmias Cardíacas / Qualidade de Vida / Exercício Físico / Cardiomiopatias Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspecto: Patient_preference Limite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Health Qual Life Outcomes Assunto da revista: SAUDE PUBLICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido